Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma.

Saved in:
Bibliographic Details
Title: Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma.
Authors: Vartanian A; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Agnihotri S; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Wilson MR; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Burrell KE; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Tonge PD; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Alamsahebpour A; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Jalali S; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Taccone MS; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Mansouri S; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Golbourn B; Arthur and Sonia Labatt Brain Tumour Research Centre, SickKids Hospital, Toronto, Canada., Aldape KD; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada., Zadeh G; MacFeeters Hamilton Center for Neuro-Oncology, Toronto, Canada.; Arthur and Sonia Labatt Brain Tumour Research Centre, SickKids Hospital, Toronto, Canada.; University Health Network, Toronto Western Hospital, Toronto, Canada.
Source: Oncotarget [Oncotarget] 2016 Oct 25; Vol. 7 (43), pp. 69518-69535.
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.11680